3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯结构式
|
常用名 | 3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯 | 英文名 | 3-Methoxy-4-oxo-1-piperidinecarboxylic acid 1,1-dimethylethyl ester |
|---|---|---|---|---|
| CAS号 | 1188265-31-7 | 分子量 | 229.273 | |
| 密度 | 1.1±0.1 g/cm3 | 沸点 | 317.8±42.0 °C at 760 mmHg | |
| 分子式 | C11H19NO4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 146.0±27.9 °C |
| 中文名 | 3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯 |
|---|---|
| 英文名 | tert-Butyl 3-methoxy-4-oxopiperidine-1-carboxylate |
| 英文别名 | 更多 |
| 密度 | 1.1±0.1 g/cm3 |
|---|---|
| 沸点 | 317.8±42.0 °C at 760 mmHg |
| 分子式 | C11H19NO4 |
| 分子量 | 229.273 |
| 闪点 | 146.0±27.9 °C |
| 精确质量 | 229.131409 |
| PSA | 55.84000 |
| LogP | 0.13 |
| 蒸汽压 | 0.0±0.7 mmHg at 25°C |
| 折射率 | 1.480 |
| 储存条件 | 2-8°C |
| 海关编码 | 2933399090 |
|---|
|
~%
3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯 1188265-31-7 |
| 文献：CONVERGENCE PHARMACEUTICALS LIMITED; WITTY, David R.; NORTON, David; TIERNEY, Jason Paul; LORTHIOIR, Ghislaine; SIME, Mairi; PHILPOTT, Karen Louise Patent: WO2012/80735 A1, 2012 ; Location in patent: Page/Page column 9; 32; 33 ; WO 2012/080735 A1 |
|
~%
3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯 1188265-31-7 |
| 文献：CONVERGENCE PHARMACEUTICALS LIMITED; WITTY, David R.; NORTON, David; TIERNEY, Jason Paul; LORTHIOIR, Ghislaine; SIME, Mairi; PHILPOTT, Karen Louise Patent: WO2012/80735 A1, 2012 ; WO 2012/080735 A1 |
|
~%
3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯 1188265-31-7 |
| 文献：CONVERGENCE PHARMACEUTICALS LIMITED; WITTY, David R.; NORTON, David; TIERNEY, Jason Paul; LORTHIOIR, Ghislaine; SIME, Mairi; PHILPOTT, Karen Louise Patent: WO2012/80735 A1, 2012 ; WO 2012/080735 A1 |
| 3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯上游产品 3 | |
|---|---|
| 3-甲氧基-4-氧代哌啶-1-羧酸叔丁酯下游产品 0 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| 1-Piperidinecarboxylic acid, 3-methoxy-4-oxo-, 1,1-dimethylethyl ester |
| tert-butyl 3-methoxy-4-oxopiperidine-1-carboxylate |
| 2-Methyl-2-propanyl 3-methoxy-4-oxo-1-piperidinecarboxylate |
